secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pyxis Oncology, Inc. (PYXS)
CIK:        0001782223
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0000950170-24-072467
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Pyxis Oncology stockholders elect four directors, ratify Ernst & Young as auditor
--------------------------------------------------------------------------------

- Dr. Santhosh Palani elected Class I director with 28,241,400 for, 93,674 withheld.
- Class III directors elected: John Flavin (21,045,395 for), Lara Sullivan (24,369,861), Jakob Dupont (28,220,452).
- Ratification of Ernst & Young as FY2024 auditor passed with 42,153,375 for, 151,087 against, 31,729 abstain.
- Quorum of 42,336,191 shares present from 58,876,390 outstanding as of record date April 18, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024072467/0000950170-24-072467-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1782223/000095017024072467/pyxs-20240611.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-072467

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer